Description
COST PER TEST REAGENT CONTRACT.
First action · last action
2012-01-09 · 2012-09-06
Transactions
2
First transaction's obligation
$24,456
Base + all options value (sum of deltas)
$24,342
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P7128A
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-01-09+$24,456= $24,456
- Mod P000012012-09-06-$114= $24,342
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-01-09 | +$24,456 | $24,456 | COST PER TEST REAGENT CONTRACT. |
| Mod P00001· FUNDING ONLY ACTION | 2012-09-06 | −$114 | $24,342 | COST PER TEST REAGENT CONTRACT. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HCNVCMEG9NL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0276 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $60,940 | FY2026 |
| 36C25726N0441 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $122,631 | FY2026 |
| 36C25726D0091 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C26226N0903 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $67,946 | FY2026 |
| 36C24926N0666 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $982,841 | FY2026 |
| 36C24126N0842 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $310,739 | FY2026 |
Other recipients under Q301 from 546-MIAMI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24812P0157 | UNIVERSITY OF MIAMI | 546-MIAMI | $169,947 | FY2012 |
| VA24812F0932 | ORTHO-CLINICAL DIAGNOSTICS, INC | 546-MIAMI | $36,055 | FY2012 |
| VA24812P0520 | MYRIAD GENETIC LABORATORIES INC | 546-MIAMI | $3,340 | FY2012 |
| VA546C10619 | PUBLIC HEALTH TRUST OF MIAMI-DADE COUNTY, FLORIDA | 546-MIAMI | $12,000 | FY2011 |
| VA546D12080 | UNIVERSITY OF MIAMI | 546-MIAMI | $20,448 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24812F1050_3600_V797P7128A_3600 · retrieved 2026-09-26.